Compare · ICCM vs MMM
ICCM vs MMM
Side-by-side comparison of IceCure Medical Ltd. (ICCM) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICCM and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $80.24B, about 7854.4x ICCM ($10.2M).
- Over the past year, ICCM is down 87.9% and MMM is up 6.7% - MMM leads by 94.6 points.
- ICCM has been more active in the news (6 items in the past 4 weeks vs 4 for MMM).
- MMM has more recent analyst coverage (25 ratings vs 2 for ICCM).
- Company
- IceCure Medical Ltd.
- 3M Company
- Price
- $3.69-15.17%
- $153.89+0.07%
- Market cap
- $10.2M
- $80.24B
- 1M return
- -50.92%
- +7.08%
- 1Y return
- -87.88%
- +6.72%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 6
- 4
- Recent ratings
- 2
- 25
IceCure Medical Ltd.
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest ICCM
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
- SEC Form 6-K filed by IceCure Medical Ltd.
- SEC Form 4 filed by VP, R&D & Engineering Muchnik Naum
- New insider Peleg Meir claimed ownership of 400,000 units of Ordinary shares (SEC Form 3)
- SEC Form 4 filed by Chief Financial Officer Tsimerman Ronen
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
- SEC Form 424B5 filed by IceCure Medical Ltd.
- SEC Form 6-K filed by IceCure Medical Ltd.
Latest MMM
- 3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- 3M Announces New Board Appointment
- SEC Form SD filed by 3M Company
- 3M Announces Upcoming Investor Event
- 3M Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Sweet Thomas W was granted 1,360 shares (SEC Form 4)
- Director Kereere Suzan was granted 1,360 shares, increasing direct ownership by 27% to 6,422 units (SEC Form 4)
- Director Fitterling James R was granted 1,360 shares (SEC Form 4)
- Director Brown Thomas K was granted 1,360 shares (SEC Form 4)
- Director Chow Anne H was granted 1,360 shares (SEC Form 4)